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Abstract
Background: Pancreatic duodenal homeobox-1 (Pdx-1) or Pdx-1-VP16 gene transfer has been
shown to induce in vitro rat liver-stem WB cell conversion into pancreatic endocrine precursor
cells. High glucose conditions were necessary for further differentiation into functional insulin-
producing cells. Pdx-1 has the ability to permeate different cell types due to an inherent protein
transduction domain (PTD). In this study, we evaluated liver-to-pancreas conversion of WB cells
following Pdx-1 or Pdx-1-VP16 protein transduction.
Findings:  WB cells were grown in high glucose medium containing Pdx-1 or Pdx-1-VP16
recombinant proteins for two weeks. β-like cell commitment was analysed by RT-PCR of
pancreatic endocrine genes. We found that WB cells in high glucose culture spontaneously express
pancreatic endocrine genes (Pdx-1, Ngn3, Nkx2.2, Kir6.2). Their further differentiation into β-like
cells expressing genes related to endocrine pancreas development (Ngn3, NeuroD, Pax4, Nkx2.2,
Nkx6.1, Pdx-1) and β-cell function (Glut-2, Kir6.2, insulin) was achieved only in the presence of Pdx-
1(-VP16) protein.
Conclusion: These results demonstrate that Pdx-1(-VP16) protein transduction is instrumental
for in vitro liver-to-pancreas conversion and is an alternative to gene therapy for β-cell engineering
for diabetes cell therapy.
Background
The difficulties encountered in obtaining sufficient supply
of transplantable β-cells is a major problem in cell therapy
of type I diabetes. Liver may be a potential source of cells
for β-cell engineering. Indeed, liver and pancreas derive
from the same endodermal region during embryogenesis
[1] and hepatocytes and β-cells share similar built-in glu-
cose-sensing systems.
Among transcription factors involved in pancreatic β-cell
specification, Pdx-1 plays a central role. All progenitors of
the endocrine as well as the exocrine pancreas express
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Pdx-1 [2,3]. In the adult, Pdx-1 expression is mainly
restrained to β-cells where it regulates important β-cell
functions like insulin transcription. Several in vitro studies,
using viral or stable plasmid gene transfer, show that Pdx-
1 expression in hepatic cells results in reprogrammation
into insulin producing cells [4-7]. Fusion of Pdx-1 to the
VP16 activation domain from Herpes simplex virus (Pdx-1-
VP16) leads to more efficient liver-to-pancreas conversion
than Pdx-1 alone [8-12]. Stable mouse Pdx-1 or Pdx-1-
VP16 gene transfection initiates conversion of rat epithe-
lial liver stem-like WB cell line into pancreatic endocrine
precursor cells [13,14]. In these cells, long-term high glu-
cose (HG) culture in vitro is necessary for further pancre-
atic endocrine differentiation.
Safety of gene therapy remaining a prime concern, protein
transduction offers a more secure alternative to induce
stem cell differentiation. Indeed, protein transduction
domains (PTD) allow proteins to translocate across the
cytoplasmic membrane. Due to an Antennapedia-like
PTD in its structure, Pdx-1 protein can permeate different
cell types and induces insulin expression in pancreatic
ducts [15,16]. However, in human embryonic stem cells,
the adjunction of a PTD domain derived from the HIV
TAT protein (TAT) is necessary for Pdx-1 cell transduction
[17]. Up to now, no study using protein transduction has
achieved liver-to-endocrine pancreas conversion in vitro.
Here, we evaluate if Pdx-1(-VP16) proteins have the
capacity to induce a pancreatic endocrine shift in WB cells.
To achieve this, we treat WB cells with Pdx-1 or Pdx-1-




Full-length mouse Pdx-1  and Pdx-1-VP16  open reading
frames were cloned into pET28b-TAT-v2-1 expression
plasmid containing the HIV TAT protein PTD (kind gift
from S. Dowdy), in order to construct Pdx-1, Pdx-1-VP16,
TAT-Pdx-1 and TAT-Pdx-1-VP16. PTDPdx-1-eGFP was con-
structed by fusing the PTD of Pdx1 (RHIKIWFQNRRMK-
WKK) to eGFP and subsequent cloning into pET28b-TAT-
v2-1. TAT-eGFP was constructed by insertion of eGFP into
pET28b-TAT-v2-1. eGFP was cloned into pET21a(+)
expression vector (Novagen, WI, USA). See Additional
data 1 for more details.
Recombinant proteins were produced according to Stud-
ier's method of auto-induction [18]. Proteins were puri-
fied by Ni2+ affinity chromatography on Protino Ni-TED
resin (Macherey-Nagel, France), diafiltrated on Centricon-
Plus-20 centrifugal filter devices (Millipore, France), and
stored at -20°C in PBS/pH8.0/25%glycerol.
Luciferase assay
The RIP2-reporter gene was constructed by cloning the [-
683 bp, +11 bp] 5' flanking region of rat insulin-II gene
into the EcoRV-site of pGL4.10 [luc2] (firefly luciferase)
(Promega, France).
18 × 103 HepG2 cells/well were seeded onto a 96-well
plate and grown 24 h in 10% FCS DMEM (5% CO2,
37°C). 0,12 μg of RIP2-reporter and 0,13 μg of HSV-TK-
hRluc control vector (renilla luciferase, pGL4-74,
Promega) were co-transfected in these cells using JetPEI
reagent (Polyplus-Transfection, France). 12 h after trans-
fection, the medium was replaced with medium contain-
ing 5 μM protein or storage buffer for negative controls.
36 h later, cells were assayed for luciferase activities using
Dual-Glo-Assay-System (Promega) and a scintillation
counter (MicroBeta-Trilux, Wallac/Perkin-Elmer, France).
WB cell culture and protein treatment
WB-F344 cells, kindly provided by N. Malouf [19], were
grown in low glucose (LG) medium: 10% FCS RPMI-1640
(11 mM glucose, Invitrogen, France) (5% CO2, 37°C).
To evaluate transduction efficiency, 50 × 103 WB cells/well
were seeded onto a 24-well plate. 24 h later, the medium
was replaced with fresh medium containing 15 μM eGFP,
PTDPdx-1-eGFP, or TAT-eGFP proteins and incubated for
another 24 h before confocal microscopy analysis.
To evaluate effects of Pdx-1(-VP16) proteins, 25 × 103 WB
cells/well (passage 15) were seeded onto a 96-well plate
with medium adjusted to HG concentration (25 mM D-
glucose, Sigma-Aldrich). 12 h later, the medium was
replaced by HG medium containing 1 μM protein (Pdx-1
(n = 4), TAT-Pdx-1 (n = 4), Pdx-1-VP16 (n = 5), or TAT-
Pdx-1-VP16 (n = 5)) or storage buffer for HG control cells
(n = 5). The medium was replaced every 3–4 days. Control
cells in LG medium (n = 5) were also grown. To favour dif-
ferentiation rather than proliferation, WB cells were
treated for 2 weeks without being trypsined. Then mRNAs
were collected and analysed by RT-PCR. Each sample (n)
represents one culture well.
Laser scanning confocal microscopy
Cells were treated 10 minutes with trypsin/EDTA, washed
with PBS, stained with Vybrant-CM-Dil (1:200 dilution in
PBS, Molecular Probes), and washed twice. eGFP signal
(λexc 488 nm, λem 507 nm) and CM-Dil staining (λexc 553
nm, λem 570 nm) were examined by laser scanning confo-
cal microscopy (Nikon TE-2000, France).
RT-PCR analysis
mRNAs were isolated with the Dynabeads-mRNA-Direct
Kit (Invitrogen). First-strand cDNA was synthesized using
M-MuLV reverse transcriptase (Promega) and randomBMC Research Notes 2009, 2:3 http://www.biomedcentral.com/1756-0500/2/3
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pentadecamer primers. The resulting cDNA was amplified
for 35 cycles [94°C 30 sec, 59/60°C 30 sec, 72°C 40 sec]
with RedTaq DNA Polymerase (Sigma-Aldrich) on a 9700
thermocycler (Applied-Biosystems, France) using primers
listed in Additional data 2.
Results
Pdx-1 and TAT PTDs transduced HepG2 and WB cells
To assess PTDPdx-1- or TAT-mediated protein transduction
in liver cells in vitro, we evaluated the ability of Pdx-1 and
TAT PTDs to deliver fusion proteins into WB and HepG2
cells. To achieve this, we produced three recombinant
eGFP fusion proteins: PTDPdx-1-eGFP, TAT-eGFP and eGFP
alone as a negative control (Fig. 1a). Intracellular eGFP
fluorescence was detected in cells treated with PTDPdx-1-
eGFP or TAT-eGFP – as punctuated or diffused signals
(Fig. 1b). No cellular uptake was detected in cells treated
with eGFP protein lacking PTD (Fig. 1b). These results
indicated clearly (i) that the efficiency of HepG2 and WB
cell transduction was dependant on the presence of a PTD
domain, and (ii) that PTDPdx-1efficiently delivered fusion
proteins into cells.
Pdx-1(-VP16) protein transduction increased insulin 
promoter activity
In order to convert WB cells into insulin producing, cells
we produced and purified four Pdx-1 proteins: Pdx-1, Pdx-
1-VP16, TAT-Pdx-1 and TAT-Pdx-1-VP16 (Fig. 2a). Rat
insulin-II promoter activity was significantly increased by
treatment with any of the Pdx-1(-VP16) proteins (Fig. 2b).
These results showed that these four Pdx-1(-VP16) pro-
teins transduced hepatic cells and, in part, went to the
nucleus and activated a β-cell specific promoter. Fusion of
TAT to these proteins, which consequently contain two
PTDs in their structure, increased insulin promoter activ-
ity in an equal manner as PTDPdx-1 alone. Pdx-1 fusion to
VP16 activation domain did not further enhance insulin
promoter activity.
Pdx-1, Pdx-1-VP16, TAT-Pdx-1 and TAT-Pdx-1-VP16 
proteins induced the expression of insulin and pancreatic-
related genes in WB cells
Whereas LG control cells expressed amylase and weakly
insulin 2, but none of the other pancreatic genes tested
here, HG control cells expressed transcription factors
implicated in endocrine pancreatic differentiation: Ngn3,
Nkx2.2 and Pdx-1 (Fig. 3). Expression of Kir6.2 was also
detected. See additional data 3 for original electrophoresis
gel images.
Taking advantage of the commitment of WB cells towards
an endocrine phenotype in HG culture, Pdx-1(-VP16)
protein treatment was performed on WB cells grown in
HG medium. Proteins induced the expression of a wide
panel of β-cell genes after two weeks of culture: NeuroD,
Pax4, Nkx6.1, insulin 1, Glut-2. Expression of Pancreatic
Polypeptide (PP), a non-β endocrine hormone, was also
detected. Among different samples, some expressed all of
these β-cell genes (Ngn3, NeuroD, Pax4, Nkx2.2, Nkx6.1,
Pdx-1, insulin 1, Glut-2, Kir6.2) and others only some of
them. Although insulin 1 was expressed, insulin 2 expres-
sion was not induced by Pdx-1(-VP16) protein treatment.
Glucokinase (GK) was not detected despite using primers
amplifying pancreatic as well as hepatic GK isoforms.
No pancreatic endocrine gene expression was observed at
earlier time points (day 6 and 9 of treatment, data not
shown).
The hepatic marker Albumin was absent in all conditions
tested, including LG control cells.
Discussion
In the present study, we demonstrate the aptitude of Pdx-
1 or Pdx-1-VP16 protein transduction to reprogram
hepatic stem-like cells into β-like cells in vitro.
First, we verified that the PTD of Pdx-1 and TAT allow
transduction into hepatic WB and HepG2 cell lines. Intra-
cellular localization of fusion proteins revealed by confo-
cal microscopy analysis indicate a true uptake of proteins
and not mere adherence to the cell surface. Furthermore,
transduced recombinant Pdx-1, TAT-Pdx-1, Pdx-1-VP16
and TAT-Pdx-1-VP16 proteins exert biological activity on
an insulin promoter reporter system. Pdx-1 fusion to
VP16 activation domain does not further enhance insulin
promoter activity consistent with previous findings [10].
Our results confirm reports of Pdx-1 transduction [15,20]
and are the first demonstration of Pdx-1-VP16 protein
transduction.
Pancreatic differentiation experiments were conducted in
an HG environment. In fact, long-term HG culture fur-
thers liver cell commitment towards a pancreatic fate
[4,6,13,14,21]. Previous studies of Pdx-1(-VP16) expres-
sion in WB cells do not distinguish between respective
contributions of transgene expression and HG culture on
differentiation. Here, we show that HG culture alone con-
verts WB cells into pancreatic endocrine precursor cells. In
contrast to LG cultures, HG cultures express four pancre-
atic endocrine genes: Ngn3, Nkx2.2, Pdx-1 and  Kir6.2.
These results concur with Yang et al. study, where conflu-
ent culture of hepatic oval stem cells for 2 months in HG
medium induces conversion into insulin-producing cells
[21]. Kir6.2 expression is at odds with previous reports
where Kir6.2 was detected in WB cells overexpressing Pdx-
1 or Pdx-1-VP16 genes only (i) after 2–3 months in HG
culture [14], (ii) 40 days post-transplantation into dia-
betic mouse [13], or (iii) after Pax4 co-expression [22].BMC Research Notes 2009, 2:3 http://www.biomedcentral.com/1756-0500/2/3
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PTDPdx-1 and TAT fusion protein synthesis and their ability to transduce HepG2 and WB cells Figure 1
PTDPdx-1 and TAT fusion protein synthesis and their ability to transduce HepG2 and WB cells. (a) Schematic 
structure (top panel) and purity (bottom panel) of fusion proteins. PTDPdx-1 and TAT represent protein transduction domains 
of the Pdx-1 protein and the HIV TAT protein, respectively. His represents hexahistidine tag used to purify proteins by His-tag 
affinity chromatography. Purified proteins were run on a SDS-PAGE gel (8%) stained with Coomassie blue. Molecular weights 
are 28 kDa for eGFP, 31 kDa for PTDPdx-1-eGFP and TAT-eGFP. (b) Observation by confocal microscopy of eGFP fluores-
cence in HepG2 and WB cells treated for 24 hours with 15 μM PTDPdx-1-eGFP, TAT-eGFP, or eGFP protein lacking PTD. 
Treated cells were observed by confocal microscopy without being fixed in order to exclude artifactual protein uptake [24]. 
CM-Dil was used to visualize cytoplasmic membrane (red staining). Scale bars = 50 μm.BMC Research Notes 2009, 2:3 http://www.biomedcentral.com/1756-0500/2/3
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Pdx-1, TAT-Pdx-1, Pdx-1-VP16, or TAT-Pdx-1-VP16 pro-
teins further induce expression of NeuroD, Pax4, Nkx6.1,
insulin 1 and Glut-2 after two weeks of treatment. Some
samples express just a part of these markers or display RT-
PCR expression patterns similar to HG controls. Quantita-
tive analysis would help to further nuance pancreatic gene
expression in-between these samples, in particular up-reg-
ulation of the endogenous Pdx-1 gene. The heterogeneity
between samples may be a consequence of: (i) infrequent
liver to endocrine pancreas conversion, leading to few
pancreatic gene positive cells which may be difficult to
detect, (ii) different kinetics of gene expression between
wells. According to Tang et al. study, our experiments do
not reveal more efficient differentiation following Pdx-1-
VP16 protein treatment compared to Pdx-1 protein treat-
ment [14]. TAT-mediated transduction does not lead to
more advanced differentiation suggesting that containing
two PTDs (PTDPdx-1 and TAT) does not increase transduc-
tion efficiency. Surprisingly, insulin 1 and Pax4, two of the
pancreatic genes expressed after our protein treatments,
are not detected in a previous in vitro study on WB cells
transduced with Pdx-1 or Pdx-1-VP16 genes, even after 3
months of HG culture [14]. Here, despite insulin 1 expres-
sion, neither insulin 2 nor glucokinase are detected pointing
at the possible need for long-term culture in HG medium
to obtain mature β-like cells [14]. Moreover, Ngn3 expres-
sion in wells scoring positive for all other pancreatic
genes, including insulin 1, suggests the presence of remain-
ing subpopulations of immature pancreatic precursor
cells.
Overexpression of Pdx-1 or Pdx-1-VP16 genes in hepatic
cells leads to exocrine as well as a range of endocrine cell
types [4,7,8,13,14]. In our study, Pdx-1(-VP16) or TAT-
Pdx-1(-VP16) protein treatments result in expression of
PP, but not of glucagon  suggesting that Pdx-1(-VP16)
transduction in hepatic stem-like cells may lead to endo-
crine  β-cell and non-β-cell phenocopies. Amylase, Figure 2
Synthesis and biological activity of Pdx-1, TAT-Pdx-1, Pdx-1- VP16 and TAT-Pdx-1-VP16 fusion proteins Figure 2
Synthesis and biological activity of Pdx-1, TAT-Pdx-1, 
Pdx-1-VP16 and TAT-Pdx-1-VP16 fusion proteins. (a) 
Schematic structure (top panel) and purity (bottom panel) of 
Pdx-1, TAT-Pdx-1, Pdx-1-VP16 and TAT-Pdx-1-VP16 fusion 
proteins. PTDPdx-1 represents protein transduction domain of 
the Pdx-1 protein, which is naturally present in the four Pdx-
1(-VP16) fusion proteins. TAT represents protein transduc-
tion domain of the VIH TAT protein. VP16 is the activation 
domain of Herpes simplex virus I. His represents hexahisti-
dine tag used to purify proteins by His-tag affinity chromatog-
raphy. Purified proteins were run on a SDS-PAGE gel (8%) 
stained with Coomassie blue. Molecular weights are 45 kDa 
for Pdx-1 and TAT-Pdx-1, 60 kDa for Pdx-1-VP16 and TAT-
Pdx-1-VP16. (b) Insulin promoter activity after Pdx-1(-VP16) 
protein transduction. Twelve hours after transient transfec-
tion of insulin promoter luciferase plasmid, HepG2 cells were 
treated with 5 μM Pdx-1(-VP16) fusion proteins for 36 
hours. Then luciferase activity was measured. Data are 
expressed as mean + SEM (Control n = 14, Pdx-1 n = 13, 
TAT-Pdx-1 n = 7, Pdx-1-VP16 n = 12, TAT-Pdx-1-VP16 n = 
19). Insulin promoter activity of controls was arbitrarily set at 
1. Statistical comparisons were performed using a non para-
metric Mann-Withney test, *: p < 0.05, ***: p < 0.001.BMC Research Notes 2009, 2:3 http://www.biomedcentral.com/1756-0500/2/3
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Gene expression profile of WB-cells treated with Pdx-1(-VP16) or TAT-Pdx-1(-VP16) proteins in high glucose culture Figure 3
Gene expression profile of WB-cells treated with Pdx-1(-VP16) or TAT-Pdx-1(-VP16) proteins in high glucose 
culture. RT-PCR analysis was performed after two weeks of protein treatment. cDNA from rat pancreas served as control 
for pancreatic gene expression, and cDNA from rat liver served as positive control for albumin expression (*). Each sample is 
represented by a single column and corresponds to an independent biological repeat of the experiment (LG (n = 5), HG (n = 
5), Pdx-1 (n = 4), TAT-Pdx-1 (n = 4), Pdx-1-VP16 (n = 5), TAT-Pdx-1-VP16 (n = 5)). Each gene is represented by a single row 
of coloured boxes. Black colouring represents RT-PCR positive samples, whereas white colouring represents negative samples. 
LG: Low Glucose control WB cells; HG: High Glucose control WB cells. (See additional data 3 for original electrophoresis gel 
images).BMC Research Notes 2009, 2:3 http://www.biomedcentral.com/1756-0500/2/3
Page 7 of 8
(page number not for citation purposes)
expressed in rat liver or exocrine pancreatic cells, is
detected in all conditions tested here [23].
Recently, Koya et al. demonstrated that Pdx-1 protein
delivery into diabetic mice restores euglycemia mainly
through pancreatic β-cell regeneration. The authors
observed β-cell gene expression and insulin synthesis in
the pancreas and in the liver of treated mice suggesting
hepatic insulin contribution to euglycemia [20]. In com-
plement, our findings provide the first direct evidence that
Pdx-1(-VP16) protein transduction in conjunction with
HG culture reprograms hepatic stem-like cells into cells
displaying similarities with β-cells  in vitro. At a point
where strategies for targeted β-cell differentiation begin to
surface, our study illustrates how simple exposition to
Pdx-1(-VP16) protein in the surrounding medium triggers
short-term pancreatic endocrine conversion. This study
may contribute to the development of protein transduc-
tion therapy, a new concept to induce β-cell differentia-
tion.
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